Carla De Faveri

This inventor holds 21 USPTO granted patents and 4 published patent applications, plus 8 CIPO patents and 17 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: H. Lundbeck A/s, Lundbeck Pharmaceuticals, Italy, Allergan, Inc.. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carla De Faveri. Retrieved from https://idiyas.com/inventor/carla-de-faveri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 4)

% Patents Active = 85.7

CIPO Patents = 8

EPO Patents = 17 (Patent Applications = 18)

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 38(Granted Patents)

Location History:

Farra di Sloigo, IT (2013)
Treviso, IT (2014)
Padua, IT (2016)
Farra di Soligo TV, IT (2019 - 2022)
Farra Di Soligo, IT (2009 - 2023)

Company Filing History:

Lundbeck Pharmaceuticals, Italy

Merz Pharma Gmbh & Co Kgaa

patents

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

Delmopinol

Inflammatory Disorders

Nalmefene

Pharmaceutical Compositions

Synthesis

Manufacturing Processes

Hydrochloride

Intermediate Products

Ritodrine

Naltrexone

Escitalopram

Isocarboxazid

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12234235 - Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders (2025-02-25),

2. 11578043 - Salt of delmopinol (2023-02-14),

3. 11384056 - Method for the manufacturing of delmopinol intermediates (2022-07-12),

4. 11332478 - Manufacture of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (2022-05-17),

5. 10894778 - Method for the manufacturing of delmopinol (2021-01-19),

6. 10815251 - Method for the manufacturing of 2-(3-(alkyl and alkenyl)morpholino)-ethan-1-ols (2020-10-27),

7. 10717747 - Method for the manufacturing of 2-(3-(alkyl and alkenyl)morpholino)-ethan-1-ols (2020-07-21),

8. 10626123 - Manufacture of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (2020-04-21),

9. 10329264 - Process for the preparation of isocarboxazid (2019-06-25),

10. 9540328 - (−)-(2R,3S)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (L)-(+) tartrate salt, its method of production and use (2017-01-10),

11. 9382247 - Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders (2016-07-05),

12. 9242935 - (-)-(2R,3S)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (L)-(+) tartrate salt, its method of production and use (2016-01-26),

13. 8912360 - Methods for preparing ritodrine hydrochloride (2014-12-16),

14. 8841452 - Process for recovery of nalmefene hydrochloride (2014-09-23),

15. 8754217 - Nalmefene hydrochloride dihydrate (2014-06-17),

Title: Innovations and Achievements of Carla De Faveri in Pharmaceutical Patents

Introduction: Carla De Faveri, hailing from Farra di Soligo, Italy, is a notable inventor in the pharmaceutical industry, holding an impressive portfolio of 18 patents. Her work primarily revolves around the development of innovative compounds and methods that significantly contribute to pharmaceutical advancements.

Latest Patents: Among her recent inventions is the patent for a non-hygroscopic salt of delmopinol, specifically the citrate salt of the compound 2-(3-(4-propylheptyl)morpholino)ethan-1-ol. This innovative formulation is significant for its potential applications in medicinal compositions. Additionally, she has developed a method for producing intermediates beneficial in the synthesis of delmopinol, involving key intermediates such as 1-chloro-4-propylhept-3-ene and 1-iodo-4-propyl-hept-3-ene.

Career Highlights: Carla has made substantial contributions in her field while working at esteemed organizations, including Lundbeck Pharmaceuticals Italy S.p.a. and H. Lundbeck A/s. Her expertise in pharmaceuticals has not only advanced product development but has also improved the overall efficacy of medications in the market.

Collaborations: Throughout her career, Carla has collaborated with notable colleagues such as Florian Anton Martin Huber and Mariano Stivanello. These partnerships have facilitated a dynamic exchange of ideas and innovations, fostering advancements in their shared field.

Conclusion: Carla De Faveri stands out as a pioneering inventor in the pharmaceutical sector, with a series of patents that underscore her commitment to innovation. Her contributions not only enhance pharmaceutical products but also exemplify the vital role that inventors play in improving health outcomes through research and development.

Profile summary based on public USPTO records.